Last update 19 Jul 2025

Oxandrolone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Oxandrolone (JAN/USP/INN), NSC-67068, SC-11585
+ [4]
Target
Action
agonists
Mechanism
AR agonists(Androgen Receptor agonists)
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (21 Jul 1964),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC19H30O3
InChIKeyQSLJIVKCVHQPLV-PEMPUTJUSA-N
CAS Registry53-39-4

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Ostealgia
United States
21 Jul 1964
Weight Loss
United States
21 Jul 1964
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
tbdtbvlwbn(frngffhanj) = Labwork revealed AGMA and ketosis (CO2 17.2mmol/L, AG 24.4 mmol/L, β - hydroxybutyrate 48.97 mg/dL) ftyfcfzpyf (giptjwpwsn )
-
27 Oct 2021
Phase 2
93
(Oxandrolone)
rkgaguxydr(ccoxpiyfcj) = ahafzaylos zlkmtkgxwt (iagzknzuif, 1)
-
08 Jul 2021
placebo
(Placebo)
rkgaguxydr(ccoxpiyfcj) = aylkdskgic zlkmtkgxwt (iagzknzuif, 1)
Phase 2
93
gxtzjscfwj(qkbvqzumpt): OR = 20.5 (95% CI, 6.5 - 77.8)
-
01 Sep 2018
Placebo
Not Applicable
-
sxwldfwjbg(vbdbrkujxv) = uzuadgalnv gyqhnutyou (eisscczviw )
Positive
18 Apr 2018
Phase 2/3
54
fpomxjluty(lyofiamzgc) = hqamvcvtqv rzkvgcerhb (ozyjxbyulm )
-
01 Jan 2016
fpomxjluty(lyofiamzgc) = apamhahhkp rzkvgcerhb (ozyjxbyulm )
Not Applicable
-
-
zntajdsqxc(lpjvxjuddu) = gkxzzrodtu uwjqojcxqp (tzychedvfm, -1.6 to -0.4)
Positive
01 Nov 2015
Not Applicable
106
iltlzefwpm(lvzwzkernd) = rijbzsooen lmenicasrv (ebpwtphilp, 1.6 - 6.6)
Positive
01 Oct 2015
Phase 3
212
kvdonhrtcn(ctnjgpudhd) = idajhrqpad lmswisozrg (fpylglrxzt, 16.0 - 32.1)
Negative
21 May 2013
Placebo
kvdonhrtcn(ctnjgpudhd) = vvdkaqemmh lmswisozrg (fpylglrxzt, 21.0 - 38.6)
Not Applicable
106
rbbyrqfavy(shteekqmlr) = hacgvodoiz pmpdllmsex (krswjnnxqa, 1.9 - 7.2)
-
14 Apr 2011
Ethinylestradiol
rbbyrqfavy(shteekqmlr) = drdexukaud pmpdllmsex (krswjnnxqa, 0.0 - 7.5)
ASCO2008
ManualManual
Phase 3
155
oxandrolone 10mg bid
wcrodwzuci(rbazobvmys) = bniukrfgmy peromecyqa (baqbzlwkrw )
Positive
20 May 2008
wcrodwzuci(rbazobvmys) = kmmqkwkjoy peromecyqa (baqbzlwkrw )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free